Medicare billing address
CMS Medicare provider billing file
7390 S Creek Rd Ste 201Sandy, UT 84093
CMS public data · NPI 1164468955
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Andrew Smith, MD
Specialty
Credential
MD
NPI
1164468955
Primary source state
UT
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Andrew Smith, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
7390 S Creek Rd Ste 201CMS Doctors & Clinicians file
6095 S Fashion BlvdCMS Doctors & Clinicians file
7390 S Creek RdIn the 2024 CMS provider billing file, this NPI had 282 Medicare beneficiaries and 27,456 total services. The average beneficiary age was 72, and the average HCC risk score was 0.9.
Total Medicare allowed amount
$625,742.15
Total Medicare payment amount
$488,351.76
Medicare beneficiaries
282
Total services
27,456
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
63%
CMS beneficiary-panel share
Asthma
60%
CMS beneficiary-panel share
Hypertension
55%
CMS beneficiary-panel share
Mood disorders
29%
CMS beneficiary-panel share
Depression
28%
CMS beneficiary-panel share
Diabetes
22%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, omalizumab, 5 mg | 7,050 | $33.07 |
| Professional service for preparation and provision of 1 or more antigens | 3,960 | $14.01 |
| Test for allergy using allergenic extract | 1,601 | $3.49 |
| Professional service for multiple injections of allergen | 1,399 | $11.65 |
| Administration and interpretation of patient-focused health risk assessment | 491 | $2.81 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 313 | $124.28 |
| Test to measure expiratory airflow and volume | 277 | $26.21 |
| Injection of drug or substance under skin or into muscle | 182 | $13.91 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 136 | $68.53 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 105 | $87.77 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1164468955. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Montelukast Sodium | Montelukast Sodium | 330 | 649.3 | $2,432.61 |
| 2 | Famotidine | Famotidine | 134 | 249.7 | $2,239.23 |
| 3 | Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 106 | 139 | $1,593.50 |
| 4 | Albuterol Sulfate Hfa | Albuterol Sulfate | 98 | 105.7 | $2,136.28 |
| 5 | Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 84 | 109 | $69,296.52 |
| 6 | Azelastine Hcl | Azelastine Hcl | 67 | 119.7 | $2,642.11 |
| 7 | Zafirlukast | Zafirlukast | 64 | 82 | $4,382.83 |
| 8 | Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 50 | 56 | $6,534.33 |
| 9 | Mometasone Furoate | Mometasone Furoate | 47 | 68.3 | $4,748.90 |
| 10 | Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 44 | 54 | $34,073.58 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Northwestern University Feinberg Medical School
Graduation year
2001
Group/practice field
Allergy Associates Of Utah Pc
Telehealth reported
Yes
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.